IDENTIFICATION OF MUTATIONS OF RESISTANCE TO FLUOROQUINOLONES, AMINOGLYCOSIDES AND ETHAMBUTOL IN RIFAMPICIN-RESISTANT MYCOBACTERIUM TUBERCULOSIS

Código QR

IDENTIFICATION OF MUTATIONS OF RESISTANCE TO FLUOROQUINOLONES, AMINOGLYCOSIDES AND ETHAMBUTOL IN RIFAMPICIN-RESISTANT MYCOBACTERIUM TUBERCULOSIS

.

Guardado en:

Detalles Bibliográficos
Autores principales:	I. V. Bakshtanovskaya, T. F. Stepanova, A. N. Ozerova, E. A. Zmatrakova, I. V. Оzhirel’eva
Formato:	article
Lenguaje:	RU
Publicado:	Sankt-Peterburg : NIIÈM imeni Pastera 2018
Materias:	Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/64fa08603ce54b868fe618dc8dcf489c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

EVOLUTION AND TRANSMISSION OF MYCOBACTERIUM TUBERCULOSIS RESISTANCE TO FLUOROQUINOLONES
por: T. Luo
Publicado: (2018)

Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan
por: Anwar Sheed Khan, et al.
Publicado: (2021)

Author Correction: Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan
por: Anwar Sheed Khan, et al.
Publicado: (2021)

High isoniazid resistance rates in rifampicin susceptible Mycobacterium tuberculosis pulmonary isolates from Pakistan.
por: Naima Fasih, et al.
Publicado: (2012)

Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics
por: Dimard E. Foudraine, et al.
Publicado: (2021)

Correlation of <i>gyr</i> Mutations with the Minimum Inhibitory Concentrations of Fluoroquinolones among Multidrug-Resistant <i>Mycobacterium tuberculosis</i> Isolates in Bangladesh
por: Mohammad Khaja Mafij Uddin, et al.
Publicado: (2021)

Aminoglycoside riboswitch control of the expression of integron associated aminoglycoside resistance adenyltransferases
por: Jun Zhang, et al.
Publicado: (2020)

Rifampicin-resistant Mycobacterium leprae in an elderly leprosy patient in the People's Republic of China
por: Yu MW, et al.
Publicado: (2013)

Rifampicin and isoniazid drug resistance among patients diagnosed with pulmonary tuberculosis in southwestern Uganda.
por: Lisa Nkatha Micheni, et al.
Publicado: (2021)

"This is not my body": Therapeutic experiences and post-treatment health of people with rifampicin-resistant tuberculosis.
por: Marian Loveday, et al.
Publicado: (2021)

Development and performance of CUHAS-ROBUST application for pulmonary rifampicin-resistance tuberculosis screening in Indonesia.
por: Bumi Herman, et al.
Publicado: (2021)

Rifampicin and isoniazid drug resistance among patients diagnosed with pulmonary tuberculosis in southwestern Uganda
por: Lisa Nkatha Micheni, et al.
Publicado: (2021)

Defining Fluoroquinolone Resistance-Mediating Mutations from Non-Resistance Polymorphisms in <i>Mycoplasma hominis</i> Topoisomerases
por: Martin Sharratt, et al.
Publicado: (2021)

DRUG RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS IN DIFFERENT LOCALIZATIONS OF THE DISEASE
por: P. K. Yablonskii, et al.
Publicado: (2016)

Analysis on Drug-Resistance-Associated Mutations among Multidrug-Resistant <i>Mycobacterium tuberculosis</i> Isolates in China
por: Hongbing Jia, et al.
Publicado: (2021)

MYCOBACTERIUM TUBERCULOSIS DRUG RESISTANCE MUTATIONS AND UNDERSTANDING OF PK/PD: TREATMENT AND CARE IMPLICATIONS
por: S. K. Heysell, et al.
Publicado: (2018)

New mutations in gidB gene associated with streptomycin resistance in Mycobacterium tuberculosis in Greece
por: Zoi Florou, et al.
Publicado: (2021)

Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multi-drug resistant tuberculosis: case control study.
por: Philly O'Riordan, et al.
Publicado: (2008)

Kinetics of kill of bacterial conjunctivitis isolates with moxifloxacin, a fluoroquinolone, compared with the aminoglycosides tobramycin and gentamicin
por: Rudolph S Wagner, et al.
Publicado: (2010)

Campylobacter: fluoroquinolone resistance in Latin-American countries
por: Fernández,H, et al.
Publicado: (2016)

GENOTYPES OF EXTENSIVELY DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS STRAINS: CLINICAL AND EPIDEMIOLOGICAL FEATURES OF PULMONARY TUBERCULOSIS
por: N. R. Vasilieva, et al.
Publicado: (2016)

Upward trends in new, rifampicin-resistant and concurrent extrapulmonary tuberculosis cases in northern Guizhou Province of China
por: Ling Chen, et al.
Publicado: (2021)

PROLIFERATIVE AND SECRETORY RESPONSE OF MONONUCLEAR LEUCOCYTES TO COMBINED INFLUENCE OF ETHAMBUTOL AND MYCOBACTERIAL ANTIGENE
por: V. A. Serebryakova, et al.
Publicado: (2014)

Characterizing the gene mutations associated with resistance to gatifloxacin in Mycobacterium tuberculosis through whole-genome sequencing
por: Jing Bi, et al.
Publicado: (2021)

Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
por: Florence O Bada, et al.
Publicado: (2020)

Health care seeking patterns of rifampicin-resistant tuberculosis patients in Harare, Zimbabwe: A prospective cohort study.
por: Rebecca Tadokera, et al.
Publicado: (2021)

In silico assigned resistance genes confer Bifidobacterium with partial resistance to aminoglycosides but not to β-lactams.
por: Fiona Fouhy, et al.
Publicado: (2013)

Dissecting the molecular evolution of fluoroquinolone-resistant Shigella sonnei
por: Hao Chung The, et al.
Publicado: (2019)

MOLECULAR BACKGROUND OF FLUOROQUINOLONE RESISTANCE IN PATHOGENIC HUMAN MYCOPLASMAS
por: A. N. Vaganova
Publicado: (2017)

MINOR GENETIC DETERMINANTS OF SECOND-LINE INJECTION DRUGS RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS
por: R. Jou, et al.
Publicado: (2018)

Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review.
por: Sophia B Georghiou, et al.
Publicado: (2012)

Drug Resistance in Mycobacterium Tuberculosis Isolates to Isoniazid and Rifampin
por: M Pourhajibagher, et al.
Publicado: (2012)

Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
por: Florence O Bada, et al.
Publicado: (2021)

Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria
por: Florence O. Bada, et al.
Publicado: (2021)

Pupillary light reflex in ethambutol-induced optic neuropathy
por: Yung-Ju Yoo, et al.
Publicado: (2020)

Whole-Genome Sequencing to Identify Missed Rifampicin and Isoniazid Resistance Among Tuberculosis Isolates—Chennai, India, 2013–2016
por: Sembulingam Tamilzhalagan, et al.
Publicado: (2021)

Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against Mycobacterium tuberculosis H37Rv strain
por: Hakkimane SS, et al.
Publicado: (2018)

DRUG RESISTANCE, VIABILITY AND VIRULENCE IN VITRO ОF MYCOBACTERIUM TUBERCULOSIS STRAINS OF DIFFERENT GENOTYPES
por: O. A. Manicheva, et al.
Publicado: (2014)

Association between fluoroquinolone resistance and MRSA genotype in Alexandria, Egypt
por: Mustafa Alseqely, et al.
Publicado: (2021)

First evaluation of drug-resistant Mycobacterium tuberculosis clinical isolates from Congo revealed misdetection of fluoroquinolone resistance by line probe assay due to a double substitution T80A-A90G in GyrA.
por: Alexandra Aubry, et al.
Publicado: (2014)